<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T01:42:19Z</responseDate>
  <request identifier="oai:figshare.com:article/34050484" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34050484</identifier>
        <datestamp>2026-10-01T21:03:52Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_915</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Effect of
Aryl Substituents in Pyridyl-Imidazopyridine
Ligands on the Aggregation-Induced Emission of Organoiridium(III)
Complexes: Implications of &lt;sup&gt;3&lt;/sup&gt;MLCT and &lt;sup&gt;3&lt;/sup&gt;ILCT Excited
States</dc:title>
          <dc:creator>Monosh Rabha (5129705)</dc:creator>
          <dc:creator>Khanindram Baruah (10783573)</dc:creator>
          <dc:creator>Deikrisha Lyngdoh Lyngkhoi (25158766)</dc:creator>
          <dc:creator>Themmila Khamrang (5775641)</dc:creator>
          <dc:creator>Rakshantha Srithar (25158769)</dc:creator>
          <dc:creator>Susnata Pramanik (3345764)</dc:creator>
          <dc:creator>Snehadrinarayan Khatua (1446796)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Physical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>photophysical studies revealed</dc:subject>
          <dc:subject>optimized structure showed</dc:subject>
          <dc:subject>offers valuable guidelines</dc:subject>
          <dc:subject>nearly parallel arrangement</dc:subject>
          <dc:subject>ilct excited states</dc:subject>
          <dc:subject>characterized using spectroscopic</dc:subject>
          <dc:subject>cell imaging studies</dc:subject>
          <dc:subject>ray diffraction analysis</dc:subject>
          <dc:subject>biological response analysis</dc:subject>
          <dc:subject>strong emission enhancement</dc:subject>
          <dc:subject>show emission due</dc:subject>
          <dc:subject>exhibited weak emission</dc:subject>
          <dc:subject>displayed pronounced aggregation</dc:subject>
          <dc:subject>three cyclometalated iridium</dc:subject>
          <dc:subject>3 &lt;/ sup</dc:subject>
          <dc:subject>cyclometalated iridium</dc:subject>
          <dc:subject>crystallographic analysis</dc:subject>
          <dc:subject>induced emission</dc:subject>
          <dc:subject>luminescent iridium</dc:subject>
          <dc:subject>unusual fluorescence</dc:subject>
          <dc:subject>successfully employed</dc:subject>
          <dc:subject>rich mixtures</dc:subject>
          <dc:subject>remained nonemissive</dc:subject>
          <dc:subject>rational design</dc:subject>
          <dc:subject>quenching mechanism</dc:subject>
          <dc:subject>naphthyl substituents</dc:subject>
          <dc:subject>lc state</dc:subject>
          <dc:subject>imidazopyridine ligands</dc:subject>
          <dc:subject>crystal x</dc:subject>
          <dc:subject>based materials</dc:subject>
          <dc:subject>aggregation state</dc:subject>
          <dc:subject>aggregated state</dc:subject>
          <dc:description>In this study, three cyclometalated iridium(III) complexes, &lt;b&gt;1[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;], 2[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt;, and &lt;b&gt;3[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt;, incorporating 3-aryl-substituted pyridyl imidazopyridine
ligands, were synthesized and characterized using spectroscopic and
single-crystal X-ray diffraction analysis. Photophysical studies revealed
that the complexes &lt;b&gt;1[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; and &lt;b&gt;2[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; exhibited weak emission in acetonitrile but displayed pronounced
aggregation-induced emission (AIE) in water-rich mixtures, whereas &lt;b&gt;3[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; remained nonemissive
both in solution and in the aggregation state. Crystallographic analysis
and DFT-optimized structure showed that the nearly parallel arrangement
of the anthracenyl and 2-phenylpyridine moieties restricts intramolecular
motion in &lt;b&gt;3[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; both in solution and aggregated state but does not show emission
due to the population of a dark &lt;sup&gt;3&lt;/sup&gt;LC state. In contrast,
the phenyl and naphthyl substituents in &lt;b&gt;1[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; and &lt;b&gt;2[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; undergo greater intramolecular motion in dilute
solution, while their restriction upon aggregation promotes a strong
emission enhancement. Additionally, biological response analysis of
complexes &lt;b&gt;1[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; and &lt;b&gt;2[PF&lt;/b&gt;&lt;sub&gt;&lt;b&gt;6&lt;/b&gt;&lt;/sub&gt;&lt;b&gt;]&lt;/b&gt; demonstrated
low cytotoxicity toward HeLa cells and the complexes were successfully
employed for live-cell imaging studies. This work provides new insights
into an unusual fluorescence-quenching mechanism in cyclometalated
iridium(III) complexes and offers valuable guidelines for the rational
design of luminescent iridium-based materials.</dc:description>
          <dc:date>2026-10-01T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.organomet.6c00217.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Effect_of_Aryl_Substituents_in_Pyridyl-Imidazopyridine_Ligands_on_the_Aggregation-Induced_Emission_of_Organoiridium_III_Complexes_Implications_of_sup_3_sup_MLCT_and_sup_3_sup_ILCT_Excited_States/34050484</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
